Dr. Adam K. Horeish, MD

Dr. Horeish practices at Fresenius Kidney Care Marina Bay in Chula Vista, California.

Dr. Horeish's NPI, 1760461206, was assigned on January 12, 2006. Dr. Horeish graduated from Ross University School of Medicine in 1998. Dr. Horeish holds California license 56089.

Dr. Horeish's primary practice is Fresenius Kidney Care Marina Bay, at 630 Bay Blvd Ste 101, Chula Vista, CA 91910 in San Diego County. The practice phone is (619) 420-6725.

Dr. Horeish's primary practice is Fresenius Kidney Care Marina Bay in Chula Vista, California. Dr. Horeish is also affiliated with Sharp Chula Vista Medical Center. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Horeish to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Horeish practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Horeish's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Horeish is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Horeish's licenses on file in 5 states: California, Arizona, Texas, Vermont and Ohio.

Dmand AI lists chronic kidney disease among the conditions Dr. Horeish treats.

CMS data shows 1,491 Medicare services from Dr. Horeish across 10 procedure codes in 2024, for 343 Medicare patients. Medicare paid $178,383 for them.

CMS counts 343 Medicare patients who saw Dr. Horeish in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 71% are also on Medicaid. Their average risk score is 5.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Horeish's median patient age at 71, with 46% women.

In 2024, Dr. Horeish wrote 2,424 Medicare Part D claims for 346 patients. 77% of them were for generic drugs. CMS names the drug for 2,148 of them, across 50 drugs with 11 or more claims each, at $641,598 in total drug cost. In 2023, CMS named 1,860 claims across 49 drugs.

Dr. Horeish accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Horeish as offering telehealth.

Dmand AI links Dr. Horeish to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus.

CMS Open Payments shows 184 general payments to Dr. Horeish from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $833.

Dr. Horeish graduated from Ross University School of Medicine in 1998.

Dr. Horeish is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.